In public health context, oncology is associated with severe negative impact on patients and
on their relatives' quality of life. Over the last decades, survival has remained at 50 …

Background International health policies and researchers have emphasized the value of
evaluating patient-reported outcomes (PROs) in clinical studies. However, the …

Objective: We sought to evaluate symptomatic adverse event (AE) rates among patients with
pancreatic cancer receiving neoadjuvant therapy on clinical trial (A021501) using the …

Introduction Online adaptive radiotherapy is well suited for stereotactic ablative radiotherapy
(SABR) in pancreatic cancer due to considerable intrafractional tumour motion. This study …

Résumé La qualité de vie et son évaluation sont des objectifs fondamentaux de la prise en
charge des patients en oncologie. Plusieurs méthodes d'évaluation de la qualité de vie des …

To explore the relationships between gastrointestinal radiation injuries of pancreatic cancer
patients treated with TOMO and dose-volume histogram parameters prospectively. Seventy …

ObjectivesPatients with metastatic upper gastrointestinal (GI) cancer may experience a large
physical symptom burden. However, less is known about existential, social, and …

Background Patients diagnosed with complex hepato-pancreaticobiliary (HPB) conditions
experience a challenging journey through the healthcare system. Patient navigation is …

Patients with pancreatic cancer usually have a very poor prognosis and have a 5-year
overall survival rate of less than 9%. Although treatment options often depend on the stage …